Altered expression of the KLF4 in colorectal cancers

Pathology Research and Practice

Volumn 202, Issue 8, 2006, Pages 585-589

  Joon Choi, Byung ^a   Gu Cho, Yong ^a   Whie Song, Jae ^a   Jae Kim, Chang ^a   Young Kim, Su ^a   Woo Nam, Suk ^a   Jin Yoo, Nam ^a   Young Lee, Jung ^a   Sang Park, Won ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

GKLF; Immunohistochemstry; Kruppel like factor; Tissue microarray

Indexed keywords

KRUPPEL LIKE FACTOR 4; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ARTICLE; CANCER LOCALIZATION; CANCER SIZE; CANCER STAGING; COLON CARCINOGENESIS; COLON MUCOSA; COLORECTAL CANCER; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PROTEIN EXPRESSION; STATISTICAL ANALYSIS; TISSUE MICROARRAY;

EID: 33745964737     PISSN: 03440338     EISSN: 16180631     Source Type: Journal    
DOI: 10.1016/j.prp.2006.05.001     Document Type: Article

References (24)

1. Astler V.B., and Coller F.A. The prognostic significance of direct extension of carcinoma of the colon and rectum. Ann. Surg. 139 (1954) 846-851
2. Chen X., Johns D.C., Geiman D.E., Marban E., Dang D.T., Hamlin G., Sun R., and Yang V.W. Krüppel-like factor 4 (gut-enriched Krüppel-like factor) inhibits cell proliferation by blocking G1/S progression of the cell cycle. J. Biol. Chem. 276 (2001) 30423-30428
3. Dang D.T., Bachman K.E., Mahatan C.S., Dang L.H., Giardiello F.M., and Yang V.W. Decreased expression of the gut-enriched Krüppel-like factor gene in intestinal adenomas of multiple intestinal neoplasia mice and in colonic adenomas of familial adenomatous polyposis patients. FEBS Lett. 476 (2000) 203-207
4. Dang D.T., Chen X., Feng J., Torbenson M., Dang L.H., and Yang V.W. Overexpression of Krüppel-like factor 4 in the human colon cancer cell line RKO leads to reduced tumorigenecity. Oncogene 22 (2003) 3424-3430
5. Fishel R., Lescoe M.K., Rao M.R., Copeland N.G., Jenkins N.A., Garber J., Kane M., and Kolodner R. The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell 75 (1993) 1027-1038
6. Foster K.W., Frost A.R., McKie-Bell P., Lin C.Y., Engler J.A., Grizzle W.E., and Ruppert J.M. Increase of GKLF messenger RNA and protein expression during progression of breast cancer. Cancer Res. 60 (2000) 6488-6495
7. Garrett-Sinha L.A., Eberspaecher H., Seldin M.F., and de Crombrugghe B. A gene for a novel zinc-finger protein expressed in differentiated epithelial cells and transiently in certain mesenchymal cells. J. Biol. Chem. 271 (1996) 31384-31390
8. Groden J., Thliveris A., Samowitz W., Carlson M., Gelbert L., Albertsen H., Joslyn G., Stevens J., Spirio L., Robertson M., Sargeant L., Krapcho K., Wolff E., Burt R., Hughes J.P., Warrington J., McPherson J., Wasmuth J., Le Paslier D., Abderrahim H., Cohen D., Leppert M., and White R. Identification and characterization of the familial adenomatous polyposis coli gene. Cell 66 (1991) 589-600
9. Gryfe R., Swallow C., Bapat B., Redstone M., Gallinger S., and Couture J. Molecular biology of colorectal cancer. Curr. Probl. Cancer 21 (1997) 233-300
10. Hermsen M., Postma C., Baak J., Weiss M., Rapallo A., Sciutto A., Roemen G., Arends J.W., Williams R., Giaretti W., De Goeij A., and Meijer G. Colorectal adenoma to carcinoma progression follows multiple pathways of chromosomal instability. Gastroenterology 123 (2002) 1109-1119
11. Katz J.P., Perreault N., Goldstein B.G., Actman L., McNally S.R., Silberg D.G., Furth E.E., and Kaestner K.H. Loss of Klf4 in mice causes altered proliferation and differentiation and precancerous changes in the adult stomach. Gastroenterology 128 (2005) 935-945
12. Kononen J., Bubendorf L., Kallioniemi A., Barlund M., Schraml P., Leighton S., Torhorst J., Mihatsch M.J., Sauter G., and Kallioniemi O.P. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat. Med. 4 (1998) 844-847
13. Nishisho I., Nakamura Y., Miyoshi Y., Miki Y., Ando H., Horii A., Koyama K., Utsunomiya J., Baba S., and Hedge P. Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. Science 253 (1991) 665-669
14. Ohnishi S., Ohnami S., Laub F., Aoki K., Suzuki K., Kanai Y., Haga K., Asaka M., Ramirez F., and Yoshida T. Downregulation and growth inhibitory effect of epithelial-type Krüppel-like transcription factor KLF4, but not KLF5, in bladder cancer. Biochem. Biophys. Res. Commun. 308 (2003) 251-256
15. Segre J.A., Bauer C., and Fuchs E. Klf4 is a transcription factor required for establishing the barrier function of the skin. Nat. Genet. 22 (1999) 356-360
16. Shie J.L., Chen Z.Y., O'brien M.J., Pestell R.G., Lee M.E., and Tseng C.C. Role of gut-enriched Krüppel-like factor in colonic cell growth and differentiation. Am. J. Physiol. Gastrointest. Liver Physiol. 279 (2000) G806-G814
17. Shields J.M., Christy R.J., and Yang V.W. Identification and characterization of a gene encoding a gut-enriched Krüppel-like factor expressed during growth arrest. J. Biol. Chem. 271 (1996) 20009-20017
18. Shields J.M., and Yang V.W. Two potent nuclear localization signals in the gut-enriched Krüppel-like factor define a subfamily of closely related krüppel proteins. J. Biol. Chem. 272 (1997) 18504-18507
19. Shin H.R., Jung K.W., Won Y.J., and Park J.G. 139 KCCR-affiliated hospitals. 2002 Annual report of the Korea central cancer registry: based on registered data from 139 hospitals. J. Korean Cancer Assoc. 36 (2004) 103-114
20. Wang N., Liu Z.H., Ding F., Wang X.Q., Zhou C.N., and Wu M. Down-regulation of gut enriched Krüppel-like factor expression in esophageal cancer. World J. Gastroenterol. 8 (2002) 966-970
21. Yet S.F., McA'Nulty M.M., Folta S.C., Yen H.W., Yoshizumi M., Hsieh C.M., Layne M.D., Chin M.T., Wang H., Perrella M.A., Jain M.K., Lee M.E., and Human E.Z.F. A Krüppel-like zinc finger protein is expressed in vascular endothelial cells and contains transcriptional activation and repression domains. J. Biol. Chem. 273 (1998) 1026-1031
22. Zhang W., Chen X., Kato Y., Evans P.M., Yuan S., Yang J., Rychahou P.G., Yang V.W., He X., Evers B.M., and Liu C. Novel cross talk of krüppel-like factor 4 and β-catenin regulates normal intestinal homeostasis and tumor regression. Mol. Cell Biol. 26 (2006) 2055-2064
23. Zhang W., Geiman D.E., Shields J.M., Dang D.T., Mahatan C.S., Kaestner K.H., Biggs J.R., Kraft A.S., and Yang V.W. The gut-enriched Krüppel-like factor (Krüppel-like factor 4) mediates the transactivating effect of p53 on the p21WAF1/Cip1 promoter. J. Biol. Chem. 275 (2000) 18391-18398
24. Zhao W., Hisamuddin I.M., Nandan M.O., Babbin B.A., Lamb N., and Yang V.W. Identification of Krüppel-like factor 4 as a potential tumor suppressor gene in colorectal cancer. Oncogene 23 (2004) 395-402